Thematic Investing

VanEck Vectors^® Pharmaceutical ETF (PPH^®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS^® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Fund Ticker
PPH
Exchange
NASDAQ
ETF Structure
Physical
Administrator
Van Eck Associates
Custodian
State Street Bank and Trust Company
Index Ticker
MVPPHTR
Index Rebalancing
Quarterly

as of 05/07/21

30-Day SEC Yield¹
1.66%
Total Net Assets
$247.4M
Number of Holdings
24
Options
Available
Gross Expense Ratio²
0.42%
Net Expense Ratio/TER²
0.35%
Distribution Frequency
Quarterly

Schedule a Call

Key Points

Highly Liquid Companies
Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume

Industry Leaders
Index methodology favors the largest companies in the industry

Global Scope
Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation

Trading Information

Fund Ticker
PPH
Index Total Return Ticker
MVPPHTR
NAV
PPHNV
Intraday NAV (IIV)⁴
PPHIV
Shares Outstanding
3,488,138
Estimated Cash
PPHEU
Total Cash
PPHTC
CUSIP
92189F692
ISIN
US92189F6925

Source: Bloomberg

Fees and Expenses²

Management Fee
0.35%
Other Expenses
0.07%
Gross Expense Ratio
0.42%
Fee Waivers and
Expense Reimbursement
-0.07%
Net Expense Ratio/TER²
0.35%

²Expenses for PPH are capped contractually at 0.35% until February 1, 2022. Cap excludes acquired fund fees and expenses, interest expense, trading expenses, taxes and extraordinary expenses.

Investment Professionals

Peter Liao, CFA

Portfolio Manager and Head of Equity ETFs
Oversees the Equity ETF Investment Management Team including development and management of index replication and optimization strategies
Joined VanEck in 2005
CFA charterholder; member of the CFA Society New York
BA, Mathematics and Economics, New York University

Guo Hua (Jason) Jin

Portfolio Manager and Analyst for Equity ETFs
Joined VanEck in 2007
Prior to his current role, held a portfolio administration position at VanEck
Previously, Portfolio Analyst at Evaluation Associates
BS, Business Administration (concentration in Financial Analysis), State University of New York at Buffalo

Griffin Driscoll

Analyst for Equity ETFs
Joined VanEck in 2018
Prior to joining VanEck, ETF Basket Operations Analyst at JPMorgan
BS, Finance, Providence College

Ralph Lasta

Analyst for Equity ETFs
Joined VanEck in 2019
Prior to VanEck, Intermediate Representative, Exchange Traded Funds at BNY Mellon.
BS, Accounting, Hunter College

Prices as of 05/07/21

	NAV/ Market Price	Volume 30-Day Avg./ Last Trading Day	Daily Change NAV/ Last Price	YTD Change NAV/ Last Price	Premium/ Discount	Prem/Discount Distribution Charts	NAV & Prem/Discount History	30-Day Median Bid Ask Spread	NAV Chart
PPH	$70.93 $70.98	163,781 36,048	$1.03 / +1.48% $1.13 / +1.62%	+7.72% +7.71%	$0.05 0.08%			--

Premium/Discount History as of 05/07/21

		Calendar Year 2020	2Q 2020	3Q 2020	4Q 2020	1Q 2021
	Days closed at a premium	124	32	29	41	32
PPH	Days closed at NAV	17	3	8	1	6
	Days closed at a discount	112	28	27	22	23

Performance History: Average Annual Total Returns* (%)
View All ETFs View All Indices

Month End as of 04/30/21
Quarter End as of 03/31/21

	1 MO	3 MO	YTD	1 YR	3 YR	5 YR	10 YR	LIFE 12/20/11
PPH (NAV)	1.45	2.70	5.69	16.74	9.03	5.58	--	9.56
PPH (Share Price)	1.24	2.55	5.55	16.78	8.98	5.53	--	9.67
MVPPHTR (Index)	1.44	2.65	5.21	16.48	8.81	5.47	--	9.47
Performance Differential (NAV - Index)	0.01	0.05	0.48	0.26	0.22	0.11	--	0.09

	1 MO	3 MO	YTD	1 YR	3 YR	5 YR	10 YR	LIFE 12/20/11
PPH (NAV)	2.26	4.18	4.18	28.94	8.76	5.74	--	9.48
PPH (Share Price)	2.21	4.25	4.25	29.23	8.70	5.77	--	9.61
MVPPHTR (Index)	2.24	3.71	3.71	28.63	8.54	5.65	--	9.39
Performance Differential (NAV - Index)	0.02	0.47	0.47	0.31	0.22	0.09	--	0.09

*Returns less than one year are not annualized.

The table presents past performance which is no guarantee of future results and which may be lower or higher than current performance. Returns reflect temporary contractual fee waivers and/or expense reimbursements. Had the ETF incurred all expenses and fees, investment returns would have been reduced. Investment returns and ETF share values will fluctuate so that investors' shares, when redeemed, may be worth more or less than their original cost. ETF returns assume that dividends and capital gains distributions have been reinvested in the Fund at NAV.

Top 10 Holdings (%) as of 04/30/21 Daily Holdings

Total Holdings: 25

Swipe
to view
full data

	Holding Name	Ticker	Shares	Market Value (US$)	% of Net Assets
	PFIZER INC	PFE US	351,247	13,575,697	5.44
	SANOFI	SNY US	255,873	13,400,069	5.37
	ASTRAZENECA PLC	AZN US	246,312	13,071,778	5.24
	ABBVIE INC	ABBV US	113,607	12,667,181	5.07
	NOVO NORDISK A/S	NVO US	171,049	12,649,074	5.07
	ZOETIS INC	ZTS US	73,092	12,647,109	5.07
	BRISTOL-MYERS SQUIBB CO	BMY US	201,359	12,568,829	5.03
	JOHNSON & JOHNSON	JNJ US	77,101	12,546,646	5.02
	NOVARTIS AG	NVS US	145,728	12,421,855	4.97
	MERCK & CO INC	MRK US	164,111	12,226,270	4.90
Top 10 Total (%)					51.18

These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Country Weightings (%) as of 04/30/21

Country
% of Net Assets
■
United States
64.83
■
United Kingdom
11.55
■
France
5.37
■
Denmark
5.07
■
Switzerland
4.97
■
Japan
3.99
■
Israel
3.68
■
Ireland
0.71
■
Other/Cash
-0.16

Sector Weightings (%) as of 04/30/21

Sector
% of Net Assets
■
Health Care
100.2
■
Other/Cash
-0.2

Thematic Investing

CEO's Investment Outlook

Related Funds

PPHVanEck Vectors Pharmaceutical ETF

Fund Description